CERo Therapeutics Holdings, Inc. Profile Avatar - Palmy Investing

CERo Therapeutics Holdings, Inc.

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell an…

Biotechnology
US, South San Francisco [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

Searching for a Dividend Aristocrat? Sign Up to view the entire dividend history of CERo Therapeutics Holdings, Inc.

  • Records
  • Forecasts [Soon]
Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of CERO's Analysis
CIK: 1870404 CUSIP: - ISIN: US71902K1051 LEI: - UEI: -
Secondary Listings
CERO has no secondary listings inside our databases.